CPhA backs extra tax on cigarettes
The board of trustees of the California Pharmacists Association (CPhA) has voted to endorse the California Cancer Research Act.
CDR
Rite Aid expands immunizations in West Virginia
In response to new state regulations, Rite Aid has broadened the range of vaccines it provides in West Virginia. Rite Aid said West Virginia has implemented new rules that allow Rite Aid pharmacists to administer more immunizations at its stores in the state.
Analysis: What many chains still lack in Rx tech
Smartphones are the new thing in efficient, on-the-go and interactive pharmacy patient services.
Rite Aid CEO John Standley elected as chairman
Next month, Rite Aid Corp. president and chief executive officer John Standley will be adding the title of chairman. Rite Aid said late Friday that Standley, who is already a member of the drug chain’s board, will become chairman on June 21 at the company’s annual shareholders meeting.
Haggen appoints pharmacy executive
Food and drug retailer Haggen Inc. has hired Guy DiPasqua as vice president of pharmacy. The company said DiPasqua brings more than 34 years in pharmacy operations in a leadership role, including as a lead for Sav-on and Osco Pharmacy operations, as well as the Target Corp.
Mylan releases HIV/AIDS medication
Mylan Inc. is launching nevirapine tablets 200 mg, indicated for the combination antiretroviral (ARV) treatment of HIV-1 infection. The company said Wednesday that its Mylan Pharmaceuticals Inc. has begun shipping the medication after receiving final approval from the Food and Drug Administration.
Endo Pharmaceuticals adopts new identity
Endo Pharmaceuticals Holdings Inc. is getting a new company name: Endo Health Solutions Inc. The company said Endo Pharmaceuticals stockholders voted in favor of the name change on Wednesday at the annual shareholders meeting.
Perrigo to launch Gynazole-1 generic
Perrigo Co. has received approval from the Food and Drug Administration for butoconazole nitrate 2% vaginal cream. The company said Tuesday that the antifungal medication, used to treat vaginal yeast infections, is the generic equivalent of Gynazole-1.
Unclear FDA drug warnings hurt adherence, CVS research finds
Drug warnings issued by the Food and Drug Administration lead some patients to eschew their medication regimens, even if the FDA didn’t advise health professionals to stop prescribing those medicines, research from CVS Caremark Corp. found.
MinuteClinic affiliates with pair of N.J. health systems
MinuteClinic has entered into clinical affiliations with Atlantic Health System and Hackensack University Health Network in New Jersey.
NACDS conveys value of community Rx on Capitol Hill
For the second time during the past week, the National Association of Chain Drug Stores has engaged with a congressional committee to highlight community pharmacy’s value to the nation’s health care system.
Shoppers Drug Mart to buy Paragon Pharmacies
Shoppers Drug Mart Corp. plans to acquire western Canada drug chain Paragon Pharmacies Ltd. for $75 million (Canadian). Announced late Tuesday, the cash deal includes Paragon’s 19 retail pharmacies and its three central fill pharmacies in British Columbia, Alberta and Manitoba.
CVS ‘free gas’ promo starts up again
CVS/pharmacy is bringing back its "Earn Free Gas" promotion, in which members of its ExtraCare loyalty program can get free gas cards this spring and summer by shopping for household essentials, health and beauty items, and snacks at stores nationwide.
Kirby Lester eases filling of 90-day scripts
Pharmacy processing of 90-day prescriptions via the Kirby Lester KL30 dispensing and verification system has been simplified thanks to a software update.
Front end more important than ever for drug chains
A catalyst for customer traffic and purchases, the front end continues to gain prominence in drug chains. Revenue from outside the pharmacy contributed more than a third of industry sales last year (35.6%), up dramatically from 28.
Novo Nordisk’s Levemir approved for wider pediatric use
The Food and Drug Administration has cleared Novo Nordisk to market its Levemir insulin for use in children ages two to five years with type 1 diabetes.